Cyteir Therapeutics Inc (CYT) Stock
CYT is no longer traded. Cyteir Therapeutics was delisted from the Nasdaq in March 2024.
Prices on this page are historical; the last trade was March 15, 2024 at $3.02.
Cyteir Therapeutics stock price history
CYT final trading statistics
- Final close
- $3.02
- Final trading day
- Mar 15, 2024
- Market cap at delisting
- $108.71M
- Shares outstanding
- 36.00M
- Final 52-week range
- $1.59 – $3.19
- Avg. volume (final 3 mo.)
- 165,711
- All-time high (split-adj.)
- $21.86 · Aug 2021
- All-time low (split-adj.)
- $1.18 · Dec 2022
- Return since IPO
- -82.6%
- Beta
- 0.10
- Book value / share
- $3.47
- Price / book
- 0.87
Cyteir Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $0.00 | -$33.2M | -$0.69 |
| FY2022 | $0.00 | -$44.0M | -$1.30 |
| FY2021 | $0.00 | -$41.6M | -$6.50 |
| FY2020 | $0.00 | -$20.8M | -$3.40 |
| FY2019 | $8.0K | -$15.0M | -$4.20 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Cyteir Therapeutics Inc
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. Cyteir Therapeutics, Inc. was incorporated in 2012 and is headquartered in Lexington, Massachusetts.
Cyteir Therapeutics stock FAQ
What happened to Cyteir Therapeutics stock?
Cyteir Therapeutics stock was delisted from the Nasdaq. Its final close was $3.02 on March 15, 2024.
Is CYT stock still trading?
No. CYT was delisted from the Nasdaq in March 2024 and no longer trades on a U.S. exchange.
What was the last price of CYT stock?
CYT closed at $3.02 on its final trading day, March 15, 2024, for a market value of about $108.71M.
What were Cyteir Therapeutics's revenue and earnings in its last full fiscal year?
Cyteir Therapeutics reported revenue of $0.00 and net income of -$33.2M in fiscal 2023, its last full year as a public company.
When did Cyteir Therapeutics go public?
Cyteir Therapeutics Inc stock began trading on June 18, 2021.